Table 1.
Measures | Low-Normal TSH (n = 88) | High-Normal TSH (n = 52) | P Value |
---|---|---|---|
Age, y | 48.9 ± 1.2a | 49.5 ± 1.8 | 0.75 |
Sex | 93% female | 87% female | 0.24 |
7% male | 13% male | ||
Estrogen status | 43% prenone | 47% prenone | 0.89 |
11% preon | 9% preon | ||
41% postnone | 42% postnone | ||
5% poston | 2% poston | ||
L-T4 time,b y | 12.4 ± 1.1 | 10.7 ± 1.1 | 0.26 |
L-T4 dose time,c y | 1.64 ± 0.23 | 2.24 ± 0.43 | 0.22 |
L-T4 dose, μg/kg | 1.51 ± 0.05d | 1.24 ± 0.06 | 0.001 |
TSH, mU/L | 1.36 ± 0.07 | 3.73 ± 0.12 | <0.0001 |
fT4, ng/dL | 1.68 ± 0.04 | 1.57 ± 0.05 | 0.09 |
fT3, pg/dL | 215 ± 5 | 209 ± 6 | 0.49 |
fT3/fT4 ratio, pg/ng | 136 ± 5 | 137 ± 5 | 0.81 |
Heart rate, beats/min | 68.0 ± 1.2 | 70.9 ± 1.7 | 0.16 |
Systolic blood pressure, mm Hg | 116.4 ± 1.6 | 116.7 ± 2.3 | 0.90 |
Diastolic blood pressure, mm Hg | 68.2 ± 0.9 | 71.6 ± 2.5 | 0.20 |
Abbreviations: Preon, premenopausal on hormone treatment; prenone, premenopausal, no hormone treatment; poston, postmenopausal on hormone treatment; postnone, postmenopausal, no hormone treatment.
Values are means ± SEM.
Duration of L-T4 therapy.
Duration of current L-T4 dose.
dSignificant differences between groups are shown in bold with corresponding P values.